Ashley Fredlock

Ashley Fredlock serves as a Market Research Analyst, playing a critical role in shaping the agency’s acquisition strategy by identifying market capabilities, evaluating supplier landscapes, and informing procurement planning for specialized healthcare and technical services. Her work ensures that contracting actions are grounded in robust market intelligence, enabling informed decisions that align with operational needs and regulatory requirements. She typically supports the development of solicitation strategies for complex professional services and medical supply acquisitions, bridging the gap between end-user requirements and market readiness. While no specific contractor relationships are currently documented, her analyses routinely inform engagements with medical laboratory operators, distributors of clinical equipment, and providers of professional scientific services. Her procurement patterns suggest a preference for established vendors with proven capacity in regulated environments, particularly those capable of meeting stringent quality and compliance standards in healthcare delivery. Fredlock’s contracting portfolio reflects a strong emphasis on open competition, with 100% of her supported acquisitions designated as “No Set-Aside.” This indicates a strategic focus on maximizing market participation through unrestricted solicitations rather than socioeconomic set-asides, though her market research may still identify qualified small businesses as competitive contenders within the broader pool. Her primary procurement focus lies in NAICS 621511 (Medical Laboratories), reflecting deep expertise in diagnostic testing infrastructure and laboratory services. She also regularly supports acquisitions under 423450 (Medical Equipment Wholesalers) and 541990 (Professional Scientific Services), indicating a technical command over clinical supply chains, diagnostic instrumentation, and specialized consulting services. Her domain knowledge spans laboratory automation, medical device distribution, and therapeutic service delivery systems, positioning her as a key advisor in the procurement of high-compliance, mission-critical healthcare solutions.